Part 2/5:
This shift in delivery method has significant benefits for patients and the healthcare system. Patients no longer have to travel to large hospitals for their treatments, reducing the burden on caregivers and the overall coordination required. Additionally, the healthcare system benefits from the cost savings associated with this more efficient delivery method.
Halo's drug delivery platform has become a significant and growing business, with the company expecting revenues of around $1 billion this year and $600 million in EBITDA. This success has led Halo to explore ways to further accelerate its growth, which has led to the company's acquisition of Evotec, a drug discovery and manufacturing company.